8-K 1 e17111_8k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2004 ROCKWELL MEDICAL TECHNOLOGIES, INC. (Exact name of registrant as specified in its Charter) Michigan 000-230-661 38-3317208 ---------------------------- ----------- ---------- (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 30142 Wixom Road, Wixom Michigan 48393 ---------------------------------------- -------- ----- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (248) 960-9009 Not applicable ------------------------------------------------------------- (Former name or former address, if changed since last report) Item 9. Regulation FD Disclosure. On February 26, 2004, the Company issued the press release attached hereto as Exhibit 99.1, announcing its financial results for the year and quarter ended December 31, 2003. Item 12. Results of Operations and Financial Condition. On February 26, 2004, the Company issued the press release attached hereto as Exhibit 99.1, announcing its financial results for the year and quarter ended December 31, 2003. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROCKWELL MEDICAL TECHNOLOGIES, INC. Date: March 1, 2004 By: /s/ Thomas E. Klema ----------------------------------- Thomas E. Klema Its: Chief Financial Officer